Private Equity 24 Hours

Last updated: May 16, 2026, 5:30 AM ET

Capital‑raising buzz in defense and physical‑world tech The week’s largest funding round saw defense‑tech unicorn Anduril Industries secure a $5 billion financing package that eclipsed all other deals, underscoring investors’ appetite for hardware‑heavy, mission‑critical solutions. Meanwhile, a compilation of “interesting startup deals” highlighted companies tackling tangible problems—ranging from a cell‑based milk producer to a law‑firm operating system—illustrating a broader trend toward physical‑world applications in venture capital. This focus aligns with a surge in capital directed toward firms that can translate lab‑bench innovations into market‑ready products, a shift that may reshape the venture landscape over the next few years.

Private‑equity acquisitions reshape the health‑care and life‑science arena Kinderhook completed a take‑private transaction of Enhabit Home Health & Hospice, paying an undisclosed sum that moved the company off the public market and into a privately held structure. The deal, led by Barb Jacobsmeyer as president and CEO, positions Enhabit to pursue growth without the quarterly reporting pressures of a public listing. Simultaneously, HIG Capital acquired International Aerospace Coatings, a supplier to OEMs and airlines, for an undisclosed amount that expands HIG’s footprint in the aerospace maintenance sector. The purchase enables HIG to tap into the growing demand for high‑performance coatings that reduce corrosion and extend aircraft life. Together, these transactions signal a continued private‑equity focus on sectors where long‑term, capital‑intensive projects can generate steady cash flows.

Strategic consolidations in medical technology and orthopedic solutions The merger of Charlesbank‑backed Tecomet with Nordic‑backed Orchid Orthopedic Solutions brings together two leaders in orthopedic device manufacturing. The combined entity will operate under the Tecomet name, streamlining operations and expanding its product line across musculoskeletal markets. The consolidation is expected to create synergies that could translate into cost savings and accelerated R&D timelines, positioning the new company to better compete against larger, multinational players. These moves reflect a broader industry trend toward consolidation as firms seek scale to fund innovation and navigate tightening regulatory environments.

Legal and regulatory wins for private‑equity firms Mercury Capital’s recent court ruling in a racial‑discrimination lawsuit marked a rare legal victory for a private‑equity firm. A jury dismissed former co‑founder claims that the firm had become a “safe haven for white men only” under former CEO Michael Ricciardi, reinforcing Mercury’s commitment to diversity and inclusion initiatives. The outcome may influence how other firms structure their workplace culture to avoid similar litigation risks and improve recruitment of diverse talent.

Strategic exits and asset transfers in Asia Schroders announced its withdrawal from a wholly‑owned China fund management business, opting to transfer its products to Neuberger Berman. The decision reflects a recalibration of Schroders’ global strategy, as it seeks to reduce exposure to regulatory uncertainties in the Chinese market while maintaining client access to Chinese assets through a partner with a stronger local presence. This move exemplifies a broader trend among Western asset managers to divest or outsource operations in regions where political or regulatory constraints limit growth prospects.

Emerging opportunities in the life‑science consulting sector Blackstone, Audax, and Five Arrows have expressed interest in acquiring pharmaceutical and life‑science consulting firms, driven by the increasing complexity of drug‑R&D pipelines. Concurrently, Eir Partners invested in Quartz Bio, a life‑sciences data‑analytics company, highlighting the strategic importance of analytics and AI in drug development. These investments suggest that private‑equity players are keen to capture value in sectors where data‑driven decision making can shorten development timelines and reduce costs.

High‑profile take‑private interests in consumer brands Blackstone and CD&R are reportedly evaluating bids for Magnum, the ice‑cream brand that has traded below its IPO price. The consideration comes as a part of a broader strategy to acquire consumer staples with strong brand equity and international distribution channels. A successful take‑private would allow the new owners to restructure operations and invest in premium product lines without the scrutiny of public markets.

Capital inflows into Dutch drone manufacturing Dutch dronemaker Destinus is reportedly in €200 m funding talks, positioning the company to scale its autonomous drone platform for industrial inspections and logistics. The capital infusion would accelerate product development and expand the firm’s customer base across Europe and beyond, capitalizing on growing demand for unmanned aerial systems in supply‑chain and infrastructure sectors.

Fund launches targeting niche founder demographics Meridian Ventures launched a $35 m fund focused on MBA‑deferred founders building enterprise technology in the United States. The fund’s strategy reflects a growing recognition that founders who delay formal business education bring unique perspectives and networks, potentially leading to differentiated growth trajectories. By supporting these founders, Meridian aims to capture early‑stage opportunities in sectors ranging from fintech to healthtech.

Sector‑specific acquisitions reinforce industry vertical focus Fusion Capital‑backed Relevant acquired Automation Werx, a Houston‑based systems integration firm serving flow‑control markets. The acquisition expands Relevant’s footprint in industrial automation, enabling it to offer end‑to‑end solutions for manufacturing and oil‑and‑gas clients. This vertical integration is poised to enhance revenue diversification and improve margins through cross‑selling opportunities.

Private‑equity interest in affordable‑care restructuring A consortium led by Blackstone and KKR is preparing to take control of Affordable Care through a debt‑restructuring that would write off roughly 70% of the company’s debt. The deal is part of a broader strategy to revitalize a provider that has struggled with high leverage and operational inefficiencies. By injecting fresh capital and strategic oversight, the consortium aims to stabilize the business and unlock long‑term value for investors.